Clinical applications of schizophrenia genetics: Genetic diagnosis, risk, and counseling in the molecular era

Application of Clinical Genetics

Volumn 5, Issue , 2012, Pages 1-18

  Costain, Gregory ^a,b   Bassett, Anne S ^a,b,c,d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

22q11 deletion syndrome; Copy number variation; Genetic counseling; Genetic predisposition to disease; Genetics; Schizophrenia

Indexed keywords

CHROMOSOME DELETION 22Q11; CLINICAL FEATURE; CLINICAL PRACTICE; COPY NUMBER VARIATION; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC MODEL; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; IDIOPATHIC DISEASE; MOLECULAR DYNAMICS; MOLECULAR EPIDEMIOLOGY; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; PENETRANCE; PSYCHIATRIC DIAGNOSIS; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; TRANSLATIONAL RESEARCH;

EID: 84864403782     PISSN: 1178704X     EISSN: None     Source Type: Journal    
DOI: 10.2147/TACG.S21953     Document Type: Review

References (291)

1. Where next with psychiatric illness? Nature. 1988;336(6195):95-96.
2. Insel TR. Rethinking schizophrenia. Nature. 2010;468(7321):187-193.
3. Bassett AS, Scherer SW, Brzustowicz LM. Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry. 2010;167(8):899-914.
4. Gejman P V, Sanders AR, Kendler KS. Genetics of schizophrenia: new findings and challenges. Annu Rev Genomics Hum Genet. 2011;12:121-144.
5. Hochstenbach R, Buizer-Voskamp JE, Vorstman JA, Ophoff RA. Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workfow and research. Cytogenet Genome Res. 2011;135(3-4):174-202.
6. Kim Y, Zerwas S, Trace SE, Sullivan PF. Schizophrenia genetics: where next? Schizophr Bull. 2011;37(3):456-463.
7. Kirov G. The role of copy number variation in schizophrenia. Expert Rev Neurother. 2010;10(1):25-32.
8. Rodriguez-Murillo L, Gogos JA, Karayiorgou M. The genetic architecture of schizophrenia: new mutations and emerging paradigms. Annu Rev Med. 2012;63:63-80.
9. Bassett AS, Chow EWC, Hodgkinson KA. Genetics of schizophrenia and psychotic disorders. In: Smoller J W, Rosen Sheidley B, Tsuang MT, editors. Psychiatric Genetics: Applications in Clinical Practice. Arlington: American Psychiatric Publishing, Inc; 2008:99-130.
10. Collier DA, Vassos E, Holden S, Patch C, McGuire P, Lewis C. Advances in the genetics of schizophrenia: will high-risk copy number variants be useful in clinical genetics or diagnostics? F1000 Med Rep. 2009;1:61.
11. Moreno-De-Luca D, Cubells JF. Copy number variants: a new molecular frontier in clinical psychiatry. Curr Psychiatry Rep. 2011; 13(2):129-137.
12. Mueser KT, Jeste D V. Clinical Handbook of Schizophrenia. New York: Guilford Press; 2008.
13. Brzustowicz LM, Bassett AS. Phenotype matters: the case for careful characterization of relevant traits. Am J Psychiatry. 2008;165(9): 1096-1098.
14. Harper PS. A Short History of Medical Genetics. New York: Oxford University Press; 2008.
15. Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry. 1998; 55(1):67-74.
16. Cardno AG, Gottesman II. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet. 2000;97(1):12-17.
17. Kendler KS, Diehl SR. The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull. 1993;19(2):261-285.
18. Kirov G, O'Donovan MC, Owen MJ. Finding schizophrenia genes. J Clin Invest. 2005;115(6):1440-1448.
19. Gottesman II, Shields J, Hanson DR. Schizophrenia, the Epigenetic Puzzle. New York: Cambridge University Press; 1982.
20. Gottesman II, Wolfgram DL. Schizophrenia Genesis: The Origins of Madness. New York: Freeman; 1991.
21. Kendler KS, Gruenberg AM, Tsuang MT. Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria. Arch Gen Psychiatry. 1985;42(8): 770-779.
22. Lowing PA, Mirsky A F, Pereira R. The inheritance of schizophrenia spectrum disorders: a reanalysis of the Danish adoptee study data. Am J Psychiatry. 1983;140(9):1167-1171.
23. Moldin SO, Gottesman II. At issue: genes, experience, and chance in schizophrenia - positioning for the 21st century. Schizophr Bull. 1997;23(4):547-561.
24. Tienari PJ, Wynne LC. Adoption studies of schizophrenia. Ann Med. 1994;26(4):233-237.
25. AbdelMalik P, Husted J, Chow EW, Bassett AS. Childhood head injury and expression of schizophrenia in multiply affected families. Arch Gen Psychiatry. 2003;60(3):231-236.
26. Byrne M, Browne R, Mulryan N, et al. Labour and delivery complications and schizophrenia. Case-control study using contemporaneous labour ward records. Br J Psychiatry. 2000;176:531-536.
27. Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM. Gene-environment interplay between cannabis and psychosis. Schizophr Bull. 2008;34(6):1111-1121.
28. McGuffn P, Asherson P, Owen M, Farmer A. The strength of the genetic effect. Is there room for an environmental infuence in the aetiology of schizophrenia? Br J Psychiatry. 1994;164(5):593-599.
29. Matheson SL, Shepherd AM, Laurens KR, Carr VJ. A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr Res. 2011;133(1-3):133-142.
30. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-328.
31. Tienari P. Implications of adoption studies on schizophrenia. Br J Psychiatry Suppl. 1992;18:52-58.
32. Wahlberg KE, Wynne LC, Oja H, et al. Gene-environment interaction in vulnerability to schizophrenia: fndings from the Finnish Adoptive Family Study of Schizophrenia. Am J Psychiatry. 1997;154(3):355-362.
33. Gottesman II, Bertelsen A. Confrming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal discordant twins. Arch Gen Psychiatry. 1989; 46(10):867-872.
34. Kringlen E, Cramer G. Offspring of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry. 1989;46(10):873-877.
35. Bassett AS, Chow EW, O'Neill S, Brzustowicz LM. Genetic insights into the neurodevelopmental hypothesis of schizophrenia. Schizophr Bull. 2001;27(3):417-430.
36. Bassett AS, Chow EW, Waterworth DM, Brzustowicz L. Genetic insights into schizophrenia. Can J Psychiatry. 2001;46(2):131-137.
37. Prasad KM, Talkowski ME, Chowdari K V, McClain L, Yolken RH, Nimgaonkar VL. Candidate genes and their interactions with other genetic/environmental risk factors in the etiology of schizophrenia. Brain Res Bull. 2010;83(3-4):86-92.
38. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet. 1990;46(2):222-228.
39. Phillips PC. Epistasis - the essential role of gene interactions in the structure and evolution of genetic systems. Nat Rev Genet. 2008;9(11): 855-867.
40. Book JA. Schizophrenia as a gene mutation. Acta Genet Stat Med. 1953; 4(2-3):133-139.
41. Penrose LS. Mutation in man. Acta Genet Stat Med. 1956;6(2): 169-182.
42. McClellan JM, Susser E, King MC. Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry. 2007;190:194-199.
43. Bassett AS, Chow EW. Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep. 2008;10(2):148-157.
44. McDonald-McGinn DM, Zackai EH. The history of the 22q11.2 deletion [webpage on the Internet]. Philadelphia, PA: Clinical Genetics Center - The Children's Hospital of Philadelphia; nd. Available from: http:// www.cbil.upenn.edu/VCFS/history.html. Accessed January 4, 2012.
45. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet. 1992;42(1):141-142.
46. Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332-339 e1.
47. Karayiorgou M, Simon TJ, Gogos JA. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci. 2010;11(6):402-416.
48. Philip N, Bassett A. Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behav Genet. 2011;41(3):403-412.
49. Sandrin-Garcia P, Abramides D V, Martelli LR, Ramos ES, Richieri-Costa A, Passos GA. Typical phenotypic spectrum of velocardiofacial syndrome occurs independently of deletion size in chromosome 22q11.2. Mol Cell Biochem. 2007;303(1-2):9-17.
50. Weksberg R, Stachon AC, Squire JA, et al. Molecular characterization of deletion breakpoints in adults with 22q11 deletion syndrome. Hum Genet. 2007;120(6):837-845.
51. Edelmann L, Pandita RK, Morrow BE. Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am J Hum Genet. 1999;64(4):1076-1086.
52. Stankiewicz P, Lupski JR. Genome architecture, rearrangements and genomic disorders. Trends Genet. 2002;18(2):74-82.
53. Bassett AS, Marshall CR, Lionel AC, Chow EW, Scherer S W. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum Mol Genet. 2008;17(24):4045-4053.
54. Cohen E, Chow EW, Weksberg R, Bassett AS. Phenotype of adults with the 22q11 deletion syndrome: A review. Am J Med Genet. 1999; 86(4):359-365.
55. Digilio MC, Angioni A, De Santis M, et al. Spectrum of clinical variability in familial deletion 22q11.2: from full manifestation to extremely mild clinical anomalies. Clin Genet. 2003;63(4): 308-313.
56. McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, et al. Phenotype of the 22q11.2 deletion in individuals identifed through an affected relative: cast a wide FISHing net! Genet Med. 2001; 3(1):23-29.
57. Costain G, Chow EW, Silversides CK, Bassett AS. Sex differences in reproductive ftness contribute to preferential maternal transmission of 22q11.2 deletions. J Med Genet. 2011;48(12):819-824.
58. Lupski JR. Genomic disorders ten years on. Genome Med. 2009; 1(4):42.
59. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 2007;370(9596):1443-1452.
60. McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore). 2011;90(1):1-18.
61. Miller DT, Adam M P, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749-764.
62. Tokuyasu TA, Cotter PD, Segraves R, et al. Detection of single clone deletions using array CGH: identifcation of submicroscopic deletions in the 22q11.2 deletion syndrome as a model system. Am J Med Genet A. 2007;143A(9):925-932.
63. Bassett AS, Chow EW, Husted J, et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A. 2005;138(4):307-313.
64. Cooper GM, Coe B P, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet. 2011;43(9):838-846.
65. Bassett AS, Costain G, Fung WL, et al. Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. J Psychiatr Res. 2010;44(15):1005-1009.
66. Fung WL, McEvilly R, Fong J, Silversides CK, Chow EWC, Bassett AS. Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome. Am J Psychiatry. 2010;167(8):998.
67. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999;56(10):940-945.
68. van Amelsvoort T, Henry J, Morris R, et al. Cognitive defcits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr Res. 2004;70(2-3):223-232.
69. Bassett AS, Chow EW, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry. 2003;160(9):1580-1586.
70. Chow EW, Watson M, Young DA, Bassett AS. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res. 2006;87(1-3):270-278.
71. Stoddard J, Niendam T, Hendren R, Carter C, Simon TJ. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophr Res. 2010;118(1-3): 118-121.
72. Torres-Juan L, Rosell J, Sanchez-de-la-Torre M, Fibla J, Heine-Suner D. Analysis of meiotic recombination in 22q11.2, a region that frequently undergoes deletions and duplications. BMC Med Genet. 2007;8:14.
73. Bassett AS, Chow EW. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry. 1999;46(7):882-891.
74. Antshel KM, Fremont W, Roizen NJ, et al. ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry. 2006;45(5):596-603.
75. Bassett AS, Chow EW, Husted J, et al. Premature death in adults with 22q11.2 deletion syndrome. J Med Genet. 2009;46(5):324-330.
76. Booij J, van Amelsvoort T, Boot E. Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: Potential role for dopamine transporter imaging. Am J Med Genet A. 2010;152A(11): 2937-2938.
77. De Smedt B, Swillen A, Verschaffel L, Ghesquiere P. Mathematical learning disabilities in children with 22q11.2 deletion syndrome: a review. Dev Disabil Res Rev. 2009;15(1):4-10.
78. Green T, Gothelf D, Glaser B, et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1060-1068.
79. Hercher L, Bruenner G. Living with a child at risk for psychotic illness: the experience of parents coping with 22q11 deletion syndrome: an exploratory study. Am J Med Genet A. 2008;146A(18):2355-2360.
80. Jolin EM, Weller RA, Jessani NR, Zackai EH, McDonald-McGinn DM, Weller EB. Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 Deletion Syndrome. J Affect Disord. 2009;119(1-3):177-180.
81. Kapadia RK, Bassett AS. Recognizing a common genetic syndrome: 22q11.2 deletion syndrome. CMAJ. 2008;178(4):391-393.
82. Lawrence S, McDonald-McGinn DM, Zackai E, Sullivan KE. Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr. 2003;143(2):277-278.
83. McDonald-McGinn DM, Kirschner R, Goldmuntz E, et al. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns. 1999;10(1):11-24.
84. McDonald-McGinn DM, Zackai EH. Genetic counseling for the 22q11.2 deletion. Dev Disabil Res Rev. 2008;14(1):69-74.
85. Oskarsdottir S, Persson C, Eriksson BO, Fasth A. Presenting pheno-type in 100 children with the 22q11 deletion syndrome. Eur J Pediatr. 2005;164(3):146-153.
86. Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet. 1997;34(10):798-804.
87. Vantrappen G, Devriendt K, Swillen A, et al. Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience. Genet Couns. 1999;10(1):3-9.
88. Zaleski C, Bassett AS, Tam K, Shugar AL, Chow EW, McPherson E. The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome. Am J Med Genet A. 2009;149A(3):525-528.
89. Chow EW, Husted J, Weksberg R, Bassett AS. Postmaturity in a genetic subtype of schizophrenia. Acta Psychiatr Scand. 2003;108(4): 260-268.
90. Gothelf D, Eliez S, Thompson T, et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci. 2005;8(11):1500-1502.
91. Vorstman JA, Chow EW, Ophoff RA, et al. Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(3):430-433.
92. Guo T, McDonald-McGinn D, Blonska A, et al. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/digeorge/22q11.2 deletion syndrome patients. Hum Mutat. 2011;32(11):1278-1289.
93. Swaby JA, Silversides CK, Bekeschus SC, et al. Complex congenital heart disease in unaffected relatives of adults with 22q11.2 deletion syndrome. Am J Cardiol. 2011;107(3):466-471.
94. Bassett AS, Caluseriu O, Weksberg R, Young DA, Chow EW. Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry. 2007;61(10):1135-1140.
95. Boot E, Booij J, Abeling N, et al. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia - relationship with COMT Val(1)/(1)Met polymorphism, gender and symptomatology. J Psychopharmacol. 2011;25(7):888-895.
96. Ikeda M, Williams N, Williams HJ, et al. Failure to confirm association between PIK4CA and psychosis in 22q11.2 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(4):980-982.
97. Antshel KM, Shprintzen R, Fremont W, Higgins AM, Faraone S V, Kates WR. Cognitive and psychiatric predictors to psychosis in velocardio-facial syndrome: a 3-year follow-up study. J Am Acad Child Adolesc Psychiatry. 2010;49(4):333-344.
98. Gothelf D, Feinstein C, Thompson T, et al. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry. 2007;164(4):663-669.
99. Gothelf D, Hoeft F, Ueno T, et al. Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome. J Psychiatr Res. 2011;45(3):322-331.
100. Chow EW, Ho A, Wei C, Voormolen EH, Crawley AP, Bassett AS. Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric defcits in the superior temporal gyrus. Am J Psychiatry. 2011;168(5):522-529.
101. Emsley R, Chiliza B, Schoeman R. Predictors of long-term outcome in schizophrenia. Curr Opin Psychiatry. 2008;21(2):173-177.
102. Bromet EJ, Kotov R, Fochtmann LJ, et al. Diagnostic shifts during the decade following first admission for psychosis. Am J Psychiatry. 2011;168(11):1186-1194.
103. Werner S, Stawski M. Knowledge, attitudes and training of professionals on dual diagnosis of intellectual disability and psychiatric disorder. J Intellect Disabil Res. 2011.
104. Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry. 2002;7(4):405-411.
105. Lewis CM, Levinson DF, Wise LH, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet. 2003;73(1):34-48.
106. Ng MY, Levinson D F, Faraone S V, et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry. 2009;14(8):774-785.
107. Owen MJ, Williams NM, O'Donovan MC. The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry. 2004;9(1):14-27.
108. Waterwort DM, Bassett AS, Brzustowicz LM. Recent advances in the genetics of schizophrenia. Cell Mol Life Sci. 2002;59(2):331-348.
109. Blouin JL, Dombroski BA, Nath SK, et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet. 1998;20(1):70-73.
110. Brzustowicz LM, Honer WG, Chow EW, et al. Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet. 1999;65(4):1096-1103.
111. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science. 2000;288(5466):678-682.
112. Ekelund J, Hovatta I, Parker A, et al. Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet. 2001;10(15):1611-1617.
113. Gurling HM, Kalsi G, Brynjolfson J, et al. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet. 2001;68(3):661-673.
114. Holmans PA, Riley B, Pulver AE, et al. Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms. Mol Psychiatry. 2009;14(8):786-795.
115. Lin M W, Sham P, Hwu HG, Collier D, Murray R, Powell JF. Suggestive evidence for linkage of schizophrenia to markers on chromosome 13 in Caucasian but not Oriental populations. Hum Genet. 1997;99(3):417-420.
116. Shaw SH, Kelly M, Smith AB, et al. A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet. 1998;81(5):364-376.
117. Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 2002;71(4): 877-892.
118. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry. 1997;2(2):148-155.
119. Vieland VJ. Thermometers: something for statistical geneticists to think about. Hum Hered. 2006;61(3):144-156.
120. Faraone S V, Hwu HG, Liu CM, et al. Genome scan of Han Chinese schizophrenia families from Taiwan: confrmation of linkage to 10q22.3. Am J Psychiatry. 2006;163(10):1760-1766.
121. Goes FS, Zandi P P, Miao K, et al. Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33. Am J Psychiatry. 2007;164(2):236-247.
122. Suarez BK, Duan J, Sanders AR, et al. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet. 2006;78(2):315-333.
123. Wratten NS, Memoli H, Huang Y, et al. Identification of a schizophrenia-associated functional noncoding variant in NOS1AP. Am J Psychiatry. 2009;166(4):434-441.
124. Gershon ES, Alliey-Rodriguez N, Liu C. After GWAS: searching for genetic risk for schizophrenia and bipolar disorder. Am J Psychiatry. 2011;168(3):253-256.
125. Athanasiu L, Mattingsdal M, Kahler AK, et al. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res. 2010;44(12): 748-753.
126. Lencz T, Morgan T V, Athanasiou M, et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry. 2007;12(6):572-580.
127. Need AC, Ge D, Weale ME, et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 2009;5(2):e1000373.
128. Schanze D, Ekici AB, Gawlik M, Pfuhlmann B, Reis A, Stober G. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population. Am J Med Genet B Neuropsychiatr Genet. 2011;156(2):198-203.
129. Sullivan P F, Lin D, Tzeng JY, et al. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry. 2008;13(6):570-584.
130. O'Donovan MC, Craddock N, Norton N, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008;40(9):1053-1055.
131. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460(7256):748-752.
132. Rietschel M, Mattheisen M, Degenhardt F, et al. Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry. 2011.
133. Ripke S, Sanders AR, Kendler KS, et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011;43(10):969-976.
134. Shi J, Levinson D F, Duan J, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009;460(7256): 753-757.
135. Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460(7256):744-747.
136. Yamada K, Iwayama Y, Hattori E, et al. Genome-wide association study of schizophrenia in Japanese population. PLoS One. 2011;6(6):e20468.
137. Yue WH, Wang HF, Sun LD, et al. Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat Genet. 2011;43(12):1228-1231.
138. Crowe RR, Thompson JS, Flink R, Weinberger B. HLA antigens and schizophrenia. Arch Gen Psychiatry. 1979;36(2):231-233.
139. Eberhard G, Franzen G, Low B. Schizophrenia susceptibility and HL-A antigen. Neuropsychobiolog y. 1975;1(4):211-217.
140. Shi Y, Li Z, Xu Q, et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat Genet. 2011;43(12):1224-1227.
141. Steinberg S, de Jong S, Andreassen OA, et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet. 2011;20(20):4076-4081.
142. Wang KS, Liu XF, Aragam N. A genome-wide meta-analysis identi-fes novel loci associated with schizophrenia and bipolar disorder. Schizophr Res. 2010;124(1-3):192-199.
143. Williams HJ, Norton N, Dwyer S, et al. Fine mapping of ZNF804A and genome-wide signifcant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry. 2011;16(4):429-441.
144. Glessner JT, Reilly M P, Kim CE, et al. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci U S A. 2010;107(23):10584-10589.
145. Arranz MJ, Rivera M, Munro JC. Pharmacogenetics of response to antipsychotics in patients with schizophrenia. CNS Drugs. 2011; 25(11):933-969.
146. Cacabelos R, Hashimoto R, Takeda M. Pharmacogenomics of antipsychotics efficacy for schizophrenia. Psychiatry Clin Neurosci. 2011; 65(1):3-19.
147. Hodgkinson KA, Murphy J, O'Neill S, Brzustowicz L, Bassett AS. Genetic counselling for schizophrenia in the era of molecular genetics. Can J Psychiatry. 2001;46(2):123-130.
148. Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and feld synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40(7):827-834.
149. Girard SL, Gauthier J, Noreau A, et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet. 2011;43(9): 860-863.
150. Xu B, Roos JL, Dexheimer P, et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet. 2011;43(9): 864-868.
151. Cook EH Jr, Scherer SW. Copy-number variations associated with neuropsychiatric conditions. Nature. 2008;455(7215):919-923.
152. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36(9):949-951.
153. Lee C, Scherer S W. The clinical context of copy number variation in the human genome. Expert Rev Mol Med. 2010;12:e8.
154. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444(7118):444-454.
155. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305(5683):525-528.
156. Bassett AS. Chromosomal aberrations and schizophrenia. Autosomes. Br J Psychiatry. 1992;161:323-334.
157. Ingason A, Kirov G, Giegling I, et al. Maternally derived microdu-plications at 15q11-q13: implication of imprinted genes in psychotic illness. Am J Psychiatry. 2011;168(4):408-417.
158. Grozeva D, Kirov G, Ivanov D, et al. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry. 2010;67(4):318-327.
159. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature. 2008;455(7210):237-241.
160. Kirov G, Grozeva D, Norton N, et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet. 2009;18(8):1497-1503.
161. Kirov G, Pocklington AJ, Holmans P, et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry. 2012;17(2):142-153.
162. Magri C, Sacchetti E, Traversa M, et al. New copy number variations in schizophrenia. PLoS One. 2010;5(10):e13422.
163. Melhem N, Middleton F, McFadden K, et al. Copy number variants for schizophrenia and related psychotic disorders in oceanic palau: risk and transmission in extended pedigrees. Biol Psychiatry. 2011;70(12):1115-1121.
164. Stefansson H, Rujescu D, Cichon S, et al. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455(7210):232-236.
165. Moreno-De-Luca D, Mulle JG, Kaminsky EB, et al. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet. 2010;87(5):618-630.
166. Levinson DF, Duan J, Oh S, et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry. 2011;168(3):302-316.
167. Ingason A, Rujescu D, Cichon S, et al. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry. 2011;16(1):17-25.
168. Brunetti-Pierri N, Berg JS, Scaglia F, et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet. 2008;40(12):1466-1471.
169. Doornbos M, Sikkema-Raddatz B, Ruijvenkamp CA, et al. Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. Eur J Med Genet. 2009;52(2-3):108-115.
170. Greenway SC, Pereira AC, Lin JC, et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet. 2009;41(8):931-935.
171. Hannes FD, Sharp AJ, Mefford HC, et al. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet. 2009;46(4):223-232.
172. Harvard C, Strong E, Mercier E, et al. Understanding the impact of 1q21.1 copy number variant. Orphanet J Rare Dis. 2011;6:54.
173. de Kovel CG, Trucks H, Helbig I, et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain. 2010;133(Pt 1):23-32.
174. Mefford HC, Clauin S, Sharp AJ, et al. Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy. Am J Hum Genet. 2007;81(5):1057-1069.
175. Mefford HC, Sharp AJ, Baker C, et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med. 2008;359(16):1685-1699.
176. Mefford HC, Cooper GM, Zerr T, et al. A method for rapid, targeted CNV genotyping identifes rare variants associated with neurocognitive disease. Genome Res. 2009;19(9):1579-1585.
177. Nagamani SC, Erez A, Shen J, et al. Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12. Eur J Hum Genet. 2010;18(3):278-284.
178. Ullmann R, Turner G, Kirchhoff M, et al. Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/ or mental retardation. Hum Mutat. 2007;28(7):674-682.
179. Williams NM, Zaharieva I, Martin A, et al. Rare chromosomal deletions and duplications in attention-defcit hyperactivity disorder: a genome-wide analysis. Lancet. 2010;376(9750):1401-1408.
180. Bassett AS. Parental origin, DNA structure, and the schizophrenia spectrum. Am J Psychiatry. 2011;168(4):350-353.
181. Horowitz A, Shifman S, Rivlin N, Pisante A, Darvasi A. A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophr Res. 2005;73(2-3):263-267.
182. Walsh T, McClellan JM, McCarthy SE, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320(5875):539-543.
183. Sporn A, Addington A, Reiss AL, et al. 22q11 deletion syndrome in childhood onset schizophrenia: an update. Mol Psychiatry. 2004;9(3):225-226.
184. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurode-velopmental model of schizophrenia: update 2005. Mol Psychiatry. 2005;10(5):434-449.
185. Girirajan S, Eichler EE. Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet. 2010;19(R2):R176-R187.
186. Costain G, Chow EW, Ray PN, Bassett AS. Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. J Intellect Disabil Res. 2011.
187. Hodgkinson K, Pullman D. Duty to warn and genetic disease. Can J Cardiovasc Nurs. 2010;20(1):12-15.
188. Piggins HD. Schizophrenia: zooming in on a gene. Nature. 2011; 471(7339):455-456.
189. Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011;470(7333):204-213.
190. Scherer S W, Dawson G. Risk factors for autism: translating genomic discoveries into diagnostics. Hum Genet. 2011;130(1):123-148.
191. Family history and BRCA 1/2 testing for identifying women at risk for inherited breast/ovarian cancer: AACE review. http://www.cdc. gov/genomics/gtesting/ACCE/fbr.htm.
192. Miller FA, Hayeems RZ, Bytautas J P. What is a meaningful result? Disclosing the results of genomic research in autism to research participants. Eur J Hum Genet. 2010;18(8):867-871.
193. Bassett AS, Bury A, Hodgkinson KA, Honer WG. Reproductive fitness in familial schizophrenia. Schizophr Res. 1996;21(3): 151-160.
194. Bundy H, Stahl D, MacCabe JH. A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives. Acta Psychiatr Scand. 2011;123(2):98-106.
195. Mitchell PB, Meiser B, Wilde A, et al. Predictive and diagnostic genetic testing in psychiatry. Clin Lab Med. 2010;30(4): 829-846.
196. Tsuang DW, Faraone S V, Tsuang MT. Genetic counseling for psychiatric disorders. Curr Psychiatry Rep. 2001;3(2):138-143.
197. Feret H, Conway L, Austin JC. Genetic counselors' attitudes towards individuals with schizophrenia: desire for social distance and endorsement of stereotypes. Patient Educ Couns. 2011;82(1): 69-73.
198. Monaco LC, Conway L, Valverde K, Austin JC. Exploring genetic counselors' perceptions of and attitudes towards schizophrenia. Public Health Genomics. 2010;13(1):21-26.
199. Finucane B. Genetic counseling for women with intellectual disabilities. In: LeRoy BS, Veach PM, Bartels DM, editors. Genetic Counseling Practice: Advanced Concepts and Skills. Hoboken: Wiley-Blackwell; 2010:470-507.
200. Taylor MR, Edwards JG, Ku L. Lost in transition: challenges in the expanding field of adult genetics. Am J Med Genet C Semin Med Genet. 2006;142C(4):294-303.
201. Farwig K, Harmon AG, Fontana KM, Mervis CB, Morris CA. Genetic counseling of adults with Williams syndrome: a frst study. Am J Med Genet C Semin Med Genet. 2010;154C(2):307-315.
202. Lee C, Iafrate AJ, Brothman AR. Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat Genet. 2007; 39(7 Suppl):S48-S54.
203. Austin JC, Peay HL. Applications and limitations of empiric data in provision of recurrence risks for schizophrenia: a practical review for healthcare professionals providing clinical psychiatric genetics consultations. Clin Genet. 2006;70(3):177-187.
204. Peay HL, Austin JC. How to Talk with Families About Genetics and Psychiatric Illness. New York: WW Norton and Company; 2011.
205. Simpson SA, Besson J, Alexander D, Allan K, Johnston AW. One hundred requests for predictive testing for Huntington's disease. Clin Genet. 1992;41(6):326-330.
206. Tyler A, Morris M, Lazarou L, Meredith L, Myring J, Harper P. Presymptomatic testing for Huntington's disease in Wales 1987-1990. Br J Psychiatry. 1992;161:481-488.
207. Xu B, Woodroffe A, Rodriguez-Murillo L, et al. Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proc Natl Acad Sci U S A. 2009;106(39): 16746-16751.
208. Al-Chalabi A, Lewis CM. Modelling the effects of penetrance and family size on rates of sporadic and familial disease. Hum Hered. 2011;71(4):281-288.
209. Yang J, Visscher PM, Wray NR. Sporadic cases are the norm for complex disease. Eur J Hum Genet. 2010;18(9):1039-1043.
210. Shulman JM, De Jager PL, Feany MB. Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol. 2011;6:193-222.
211. Guttmacher AE, Collins FS, Carmona RH. The family history - more important than ever. N Engl J Med. 2004;351(22):2333-2336.
212. Papadimitriou GN, Dikeos DG. How does recent knowledge on the heredity of schizophrenia affect genetic counseling? Curr Psychiatry Rep. 2003;5(4):239-240.
213. Reveley A. Genetic counselling for schizophrenia. Br J Psychiatry. 1985;147:107-112.
214. Tsuang MT. Genetic counseling for psychiatric patients and their families. Am J Psychiatry. 1978;135(12):1465-1475.
215. Hunter MJ, Hippman C, Honer WG, Austin JC. Genetic counseling for schizophrenia: a review of referrals to a provincial medical genetics program from 1968 to 2007. Am J Med Genet A. 2010;152A(1): 147-152.
216. Lyus VL. The importance of genetic counseling for individuals with schizophrenia and their relatives: potential clients' opinions and experiences. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(8):1014-1021.
217. Austin JC, Honer WG. Psychiatric genetic counselling for parents of individuals affected with psychotic disorders: a pilot study. Early Interv Psychiatry. 2008;2(2):80-89.
218. Torrey EF. Surviving Schizophrenia: A Manual for Families, Patients, and Providers. 5th ed. New York, NY: Collins; 2006.
219. Bruder CE, Piotrowski A, Gijsbers AA, et al. Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet. 2008;82(3):763-771.
220. Dempster EL, Pidsley R, Schalkwyk LC, et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011;20(24):4786-4796.
221. Kato T, Iwamoto K, Kakiuchi C, Kuratomi G, Okazaki Y. Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Mol Psychiatry. 2005;10(7):622-630.
222. Maiti S, Kumar KH, Castellani CA, O'Reilly R, Singh SM. Ontogenetic de novo copy number variations (CNVs) as a source of genetic individuality: studies on two families with MZD twins for schizophrenia. PLoS One. 2011;6(3):e17125.
223. Husted JA, Ahmed R, Chow EW, Brzustowicz LM, Bassett AS. Childhood trauma and genetic factors in familial schizophrenia associated with the NOS1AP gene. Schizophr Res. 2010;121(1-3):187-192.
224. van Os J, Kenis G, Rutten B P. The environment and schizophrenia. Nature. 2010;468(7321):203-212.
225. Kurnit DM, Layton WM, Matthysse S. Genetics, chance, and morphogenesis. Am J Hum Genet. 1987;41(6):979-995.
226. Ruvinsky A. Genetics and Randomness. Boca Raton, FL: CRC Press; 2010.
227. Lichtenstein P, Bjork C, Hultman CM, Scolnick E, Sklar P, Sullivan P F. Recurrence risks for schizophrenia in a Swedish national cohort. Psychol Med. 2006;36(10):1417-1425.
228. Slatkin M. Genotype-specific recurrence risks as indicators of the genetic architecture of complex diseases. Am J Hum Genet. 2008;83(1):120-126.
229. Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 2007;17(10):1520-1528.
230. Slatkin M. Epigenetic inheritance and the missing heritability problem. Genetics. 2009;182(3):845-850.
231. Lander ES. Initial impact of the sequencing of the human genome. Nature. 2011;470(7333):187-197.
232. Drmanac R. The advent of personal genome sequencing. Genet Med. 2011;13(3):188-190.
233. Greenspan SI, Brazelton TB, Cordero J, et al. Guidelines for early identifcation, screening, and clinical management of children with autism spectrum disorders. Pediatrics. 2008;121(4):828-830.
234. Miles JH. Autism spectrum disorders - a genetics review. Genet Med. 2011;13(4):278-294.
235. Kjeldsen MJ, Kyvik KO, Christensen K, Friis ML. Genetic and environmental factors in epilepsy: a population-based study of 11900 Danish twin pairs. Epilepsy Res. 2001;44(2-3):167-178.
236. Mulley JC, Dibbens LM. Genetic variations and associated pathophysi-ology in the management of epilepsy. The Application of Clinical Genetics. 2011;4:113-125.
237. Pal DK, Pong AW, Chung WK. Genetic evaluation and counseling for epilepsy. Nat Rev Neurol. 2010;6(8):445-453.
238. Poduri A, Lowenstein D. Epilepsy genetics - past, present, and future. Curr Opin Genet Dev. 2011;21(3):325-332.
239. Sharma K. Genetic epidemiology of epilepsy: a twin study. Neurol India. 2005;53(1):93-98.
240. Do CB, Tung JY, Dorfman E, et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet. 2011;7(6):e1002141.
241. Elbaz A, Bower JH, Maraganore DM, et al. Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol. 2002;55(1):25-31.
242. Schulte C, Gasser T. Genetic basis of Parkinson's disease: inheritance, penetrance, and expression. The Application of Clinical Genetics. 2011;4(67-80):67.
243. Toft M, Ross OA. Copy number variation in Parkinson's disease. Genome Med. 2010;2(9):62.
244. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011;377(9770):1019-1031.
245. Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer disease: back to the future. Neuron. 2010;68(2):270-281.
246. Gatz M, Reynolds CA, Fratiglioni L, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168-174.
247. Goldman JS, Hahn SE, Catania J W, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med. 2011;13(6):597-605.
248. Coulter ME, Miller DT, Harris DJ, et al. Chromosomal microarray testing infuences medical management. Genet Med. 2011;13(9): 770-776.
249. Basel-Vanagaite L, Goldberg-Stern H, Mimouni-Bloch A, Shkalim V, Bohm D, Kohlhase J. An emerging 1q21.1 deletion-associated neu-rodevelopmental phenotype. J Child Neurol. 2011;26(1):113-116.
250. Brunet A, Armengol L, Heine D, et al. BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1. BMC Med Genet. 2009;10:144.
251. Christiansen J, Dyck JD, Elyas BG, et al. Chromosome 1q21.1 contiguous gene deletion is associated with congenital heart disease. Circ Res. 2004;94(11):1429-1435.
252. Ikeda M, Aleksic B, Kirov G, et al. Copy number variation in schizophrenia in the Japanese population. Biol Psychiatry. 2010;67(3): 283-286.
253. Sahoo T, Theisen A, Rosenfeld JA, et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet Med. 2011;13(10):868-880.
254. Vu TH, Coccaro EF, Eichler EE, Girirajan S. Genomic architecture of aggression: rare copy number variants in intermittent explosive disorder. Am J Med Genet B Neuropsychiatr Genet. 2011;156B(7): 808-816.
255. Ballif BC, Theisen A, Coppinger J, et al. Expanding the clinical phe-notype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet. 2008;1:8.
256. Clayton-Smith J, Giblin C, Smith RA, Dunn C, Willatt L. Familial 3q29 microdeletion syndrome providing further evidence of involvement of the 3q29 region in bipolar disorder. Clin Dysmorphol. 2010;19(3):128-132.
257. Digilio MC, Bernardini L, Mingarelli R, et al. 3q29 Microdeletion: a mental retardation disorder unassociated with a recognizable pheno-type in two mother-daughter pairs. Am J Med Genet A. 2009;149A(8): 1777-1781.
258. Mulle JG, Dodd A F, McGrath JA, et al. Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet. 2010;87(2):229-236.
259. Quintero-Rivera F, Sharifi-Hannauer P, Martinez-Agosto JA. Autistic and psychiatric fndings associated with the 3q29 microde-letion syndrome: case report and review. Am J Med Genet A. 2010;152A(10):2459-2467.
260. Vacic V, McCarthy S, Malhotra D, et al. Duplications of the neuro-peptide receptor gene VIPR2 confer signifcant risk for schizophrenia. Nature. 2011;471(7339):499-503.
261. Willatt L, Cox J, Barber J, et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet. 2005;77(1):154-160.
262. Browne CE, Dennis NR, Maher E, et al. Inherited interstitial duplications of proximal 15q: genotype-phenotype correlations. Am J Hum Genet. 1997;61(6):1342-1352.
263. Chamberlain SJ, Lalande M. Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13. Neurobiol Dis. 2010;39(1):13-20.
264. Cook EH Jr, Lindgren V, Leventhal BL, et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet. 1997;60(4):928-934.
265. Gurrieri F, Battaglia A, Torrisi L, et al. Pervasive developmental disorder and epilepsy due to maternally derived duplication of 15q11-q13. Neurolog y. 1999;52(8):1694-1697.
266. Hogart A, Wu D, LaSalle JM, Schanen NC. The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol Dis. 2010;38(2):181-191.
267. Michelson M, Eden A, Vinkler C, et al. Familial partial trisomy 15q11-13 presenting as intractable epilepsy in the child and schizophrenia in the mother. Eur J Paediatr Neurol. 2011;15(3):230-233.
268. Thomas JA, Johnson J, Peterson Kraai TL, et al. Genetic and clinical characterization of patients with an interstitial duplication 15q11-q13, emphasizing behavioral phenotype and response to treatment. Am J Med Genet A. 2003;119A(2):111-120.
269. Ben-Shachar S, Lanpher B, German JR, et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet. 2009;46(6):382-388.
270. van Bon B W, Mefford HC, Menten B, et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet. 2009;46(8):511-523.
271. Cubells J F, Deoreo EH, Harvey PD, et al. Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome. Am J Med Genet A. 2011;155A(4):805-810.
272. Dibbens LM, Mullen S, Helbig I, et al. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum Mol Genet. 2009;18(19): 3626-3631.
273. Helbig I, Mefford HC, Sharp AJ, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet. 2009;41(2): 160-162.
274. Masurel-Paulet A, Andrieux J, Callier P, et al. Delineation of 15q13.3 microdeletions. Clin Genet. 2010;78(2):149-161.
275. Miller DT, Shen Y, Weiss LA, et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet. 2009;46(4):242-248.
276. Pagnamenta AT, Wing K, Sadighi Akha E, et al. A 15q13.3 microdeletion segregating with autism. Eur J Hum Genet. 2009;17(5):687-692.
277. Sharp AJ, Mefford HC, Li K, et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet. 2008;40(3):322-328.
278. Shinawi M, Schaaf C P, Bhatt SS, et al. A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet. 2009;41(12):1269-1271.
279. Bedoyan JK, Kumar RA, Sudi J, et al. Duplication 16p11.2 in a child with infantile seizure disorder. Am J Med Genet A. 2010;152A(6): 1567-1574.
280. Fernandez BA, Roberts W, Chung B, et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet. 2010;47(3):195-203.
281. Lionel AC, Crosbie J, Barbosa N, et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med. 2011;3(95):95ra75.
282. McCarthy SE, Makarov V, Kirov G, et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet. 2009;41(11): 1223-1227.
283. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008;82(2): 477-488.
284. Rosenfeld JA, Coppinger J, Bejjani BA, et al. Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications. J Neurodev Disord. 2010;2(1):26-38.
285. Schaaf C P, Goin-Kochel R P, Nowell K P, et al. Expanding the clinical spectrum of the 16p11.2 chromosomal rearrangements: three patients with syringomyelia. Eur J Hum Genet. 2011;19(2):152-156.
286. Shen Y, Dies KA, Holm IA, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics. 2010;125(4):e727-e735.
287. Shinawi M, Liu P, Kang SH, et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet. 2010;47(5):332-341.
288. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med. 2008; 358(7):667-675.
289. Goodship J, Cross I, LiLing J, Wren C. A population study of chromosome 22q11 deletions in infancy. Arch Dis Child. 1998;79(4): 348-351.
290. Rees E, Moskvina V, Owen MJ, O'Donovan MC, Kirov G. De novo rates and selection of schizophrenia-associated copy number variants. Biol Psychiatry. 2011;70(12):1109-1114.
291. Vassos E, Collier DA, Holden S, et al. Penetrance for copy number variants associated with schizophrenia. Hum Mol Genet. 2010;19(17): 3477-3481.